Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/285305 
Year of Publication: 
2023
Citation: 
[Journal:] Health Economics Review [ISSN:] 2191-1991 [Volume:] 13 [Issue:] 1 [Article No.:] 4 [Year:] 2023 [Pages:] 1-11
Publisher: 
Springer, Heidelberg
Abstract: 
Background: More than two years into the coronavirus disease (COVID-19) pandemic, it remains unclear whether fnancial incentives can reduce vaccine hesitancy and improve uptake among key unvaccinated populations. This study estimated the willingness of racial/ethnic minority adults in the United States to accept fnancial incentives for COVID-19 vaccination and the minimum amount needed to vaccinate a sufciently high percentage of this population. Methods: From August through September 2021, we conducted an online survey of 367 Black/African American and Hispanic patients, age=18 years, from 8 community health centers in Rhode Island. Contingent valuation questions assessed respondents' willingness-to-accept (WTA) incentives for COVID-19 vaccination using random-startingpoints and iterative incentive ofers of $5 to $50 per dose. Ordered logistic regression models examined associations between respondent characteristics and WTA. Predictive probabilities were modeled using both within-survey range and out-of-survey range incentive ofer amounts and compared against vaccination thresholds needed to reach herd immunity. Results: Less than 30% of unvaccinated survey respondents were WTA an incentive of $50/dose for vaccination. Mod- els using out-of-survey incentive ofer amounts greater than $50 suggested that 85% of respondents would agree $140/dose (95% CI: $43-$236) could convince other people to accept vaccination, while $209/dose (95% CI: -$91$509) would be needed for 85% of respondents to accept vaccination themselves. Conclusions: Findings from this analysis may inform the design of incentive schemes aiming to reduce racial/ethnic disparities in vaccine and booster uptake, which will continue to be important as new variants of SARS-CoV-2 emerge.
Subjects: 
Financial incentives
Vaccination
COVID-19
Contingent valuation
Willingness-to-accept
United States
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.